Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares, rose in value on Friday, June 20, with the stock price down by -5.71% to the previous day’s close as strong demand from buyers drove the stock to $32.36. Actively observing the price movement in the last trading, the
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price on current trading day, fall -9.30% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $34.20. A look at the stock’s price movement, the level at last check in today’s session was
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) traded at $39.78 at close of the session on Friday, May 30 and made a downward move of -5.33% on its previous day’s price. Tonix Pharmaceuticals Holding Corp has a market cap of $291.38 million and is expected to release
The trading price of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) closed higher on Friday, May 23, and closing at $31.60, 9.23% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $29.74 and $32.3. In examining
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price closed higher on Tuesday, May 20, and jumping 12.41% above its previous close. A look at the daily price movement shows that the last close reads $26.60, with intraday deals fluctuated between $25.11 and $30.74. The company’s 5Y monthly
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price closed lower on current market day and dropping -5.00% below its previous close. A look at the daily price movement shows that the last close reads $28.00. Taking into account the 52-week price action we note that the stock
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) at last check was buoying at $27.08 on current market day with a rise of 17.23% from its closing price on previous day. Considering stock’s 52-week price range provides that TNXP hit a high price of $672.00 and saw its
Today we peer into the world of biotech stocks! This is a space that is often overlooked by investors for being too high-risk, but experts realize that this industry is much more than getting a good candidate through clinical trials. In recent years, biotechnology has
As with the rest of the economy, the turmoil of Covid-19 has also affected blue-chip stocks and stocks under $1. As new strains of the disease are spreading, it is clear that the pandemic has not yet been eradicated globally. This has led to more
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.